Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-990 Cr₹-856 Cr₹-288 Cr₹122 Cr₹122 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA is ₹-990 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-990 Cr
Mar2024₹-856 Cr
Mar2023₹-288 Cr
Mar2022₹122 Cr
Mar2021₹122 Cr

How is Deferred Tax Assets / Liabilities of AUROBINDO PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-990 Cr
Negative
Mar2024 ₹-856 Cr
Negative
Mar2023 ₹-288 Cr
Negative
Mar2022 ₹122 Cr
0.40
Mar2021 ₹122 Cr -

Compare Deferred Tax Assets / Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹79,436.0 Cr 2.1% 6.9% 28% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,209.0 Cr 1% -6.4% -0.7% Stock Analytics
DIVIS LABORATORIES ₹166,750.0 Cr 3.5% 3.4% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,746.0 Cr 0.2% -1.8% 33.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,851.0 Cr -0.2% -3.4% 11.4% Stock Analytics
CIPLA ₹99,268.4 Cr 1.5% -5.4% -15.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

2.1%

6.9%

28%

SENSEX

1.3%

5.3%

6.3%


You may also like the below Video Courses